0.00Open0.00Pre Close0 Volume0 Open Interest33.00Strike Price0.00Turnover474.87%IV-90.86%PremiumDec 20, 2024Expiry Date15.71Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8160Delta0.0280Gamma1.05Leverage Ratio-0.2494Theta-0.0035Rho-0.86Eff Leverage0.0053Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet